Vodafone Certified application status for the MedifyRemote™ application

vodafoneMedify Solutions Limited announced that it has been awarded Vodafone Certified application status for its MedifyRemote™ application. MedifyRemote™ is the first application of its type and allows healthcare professionals mobile access to review and update a patients' medical history records in a single, secure session via a standard Microsoft Windows Mobile PDA/phone device. The application offers no interference with the existing device functions, enabling one device to be utilised for telephone, email, calendar, internet access; as well patient note functions.

In order to achieve Vodafone Certified status, MedifyRemote™ underwent technical evaluation by Vodafone UK. As a result, the application has passed the approval process, meeting the high standards demanded by Vodafone UK's customer base and delivering value to the UK marketplace.

As a Certified application, Medify Solutions Limited now has access to Vodafone UK's technical expertise and will be recommended to appropriate customers by Vodafone UK account managers. MedifyRemote™ will be identified by the "Vodafone Certified Application" brand logo. This will allow Medify Solutions Limited to benefit from Vodafone UK's position as the UK's largest mobile network operator, offering its customers in-depth support and peace of mind when deploying new mobile applications.

Ian O'Reilly, CEO Medify Solutions Limited, said: "Gaining Vodafone Certified status represents a superb endorsement for the MedifyRemote™ application. Our mobile application is successfully leading the way in the UK NHS and the rapid development of the e-Healthcare sector. The recognition of the importance of MedifyRemote™ by a major organisation such as Vodafone UK, underlines the value that this application delivers to clinical users and partners alike. We are very much looking forward to continuing the strong partnership we have formed with Vodafone UK."

Nick Parbutt, Head of Enterprise Product, Vodafone UK said: "For many of our customers, mobile data applications, such as job scheduling or workforce management are a business imperative. Having experienced the business benefits that such applications deliver, these customers are now considering additional solutions to address day-to-day business requirements. Medify Solutions Limited has proven that it can address these needs and we look forward to working with its team to enable our customers to realise the efficiencies that MedifyRemote™ delivers."

MedifyRemote™ joins a number of other Certified application developers in the Vodafone UK applications portfolio which have developed solutions ranging from telematics and sales solutions to tools that replicate the functionality or content from the desktop environment on to the mobile device.

Those interested in further information should email This email address is being protected from spambots. You need JavaScript enabled to view it. or visit www.medifysolutions.com

About the Medify Solutions
The Medify Solutions group of companies are focused on the development, taking to market and delivery of leading edge mobile solutions for the healthcare market. With operations across the EU, Medify are at the forefront of the technology revolution in patient care. For more information, please visit www.medifysolutions.com.

About Vodafone UK
Vodafone UK has 16.3 million customers and is part of the world’s leading international mobile telecommunications Group, offering a wide range of voice and data communications. The company is committed to providing mobile solutions that allow both consumer and business customers to make the most of now. In addition, Vodafone connects customers across the globe with roaming agreements worldwide. It provides 3G roaming in 29 countries and offers great roaming value with Vodafone Passport. For more information, please visit www.vodafone.co.uk.

Most Popular Now

Open Medical Works with Moray's Dig…

Open Medical is working with the Digital Health & Care Innovation Centre’s Rural Centre of Excellence on a referral management plan, as part of a research and development scheme to...

Generative AI on Track to Shape the Futu…

Using advanced artificial intelligence (AI), researchers have developed a novel method to make drug development faster and more efficient. In a new paper, Xia Ning, lead author of the study and...

AI could Help Improve Early Detection of…

A new study led by investigators at the UCLA Health Jonsson Comprehensive Cancer Center suggests that artificial intelligence (AI) could help detect interval breast cancers - those that develop between...

Reorganisation, Consolidation, and Cuts:…

NHS England has been downsized and abolished. Integrated care boards have been told to change function, consolidate, and deliver savings. Trusts are planning big cuts. The Highland Marketing advisory board...

AI-Human Task-Sharing could Cut Mammogra…

The most effective way to harness the power of artificial intelligence (AI) when screening for breast cancer may be through collaboration with human radiologists - not by wholesale replacing them...

Siemens Healthineers infection Control S…

Klinikum Region Hannover (KRH) has commissioned Siemens Healthineers to install infection control system (ICS) at the Klinikum Siloah hospital. The ICS aims to effectively tackle nosocomial infections and increase patient...

AI Tool Uses Face Photos to Estimate Bio…

Eyes may be the window to the soul, but a person's biological age could be reflected in their facial characteristics. Investigators from Mass General Brigham developed a deep learning algorithm...

Philips Future Health Index 2025 Report …

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today unveiled its 2025 Future Health Index U.S. report, "Building trust in healthcare AI," spotlighting the state of...

AI-Powered Precision: Unlocking the Futu…

A team of researchers from the Department of Diagnostic and Therapeutic Ultrasonography at the Tianjin Medical University Cancer Institute & Hospital, have published a review in Cancer Biology & Medicine...

AI Model Improves Delirium Prediction, L…

An artificial intelligence (AI) model improved outcomes in hospitalized patients by quadrupling the rate of detection and treatment of delirium. The model identifies patients at high risk for delirium and...

Building Trust in Artificial Intelligenc…

A new review, published in the peer-reviewed journal AI in Precision Oncology, explores the multifaceted reasons behind the skepticism surrounding artificial intelligence (AI) technologies in healthcare and advocates for approaches...

SALSA: A New AI Tool for the Automated a…

Investigators of the Vall d'Hebron Institute of Oncology's (VHIO) Radiomics Group, led by Raquel Perez-Lopez, have developed SALSA (System for Automatic Liver tumor Segmentation And detection), a fully automated deep...